How People Try to Beat Drug Testing and Defend Positive Results
|
By Kim Scott (AACC) Posted on 12 Jul 2022 |

Image: How People Try to Beat Drug Testing and Defend Positive Results (Photo courtesy of aacc.org)
Drug abuse is a critical problem throughout the world. While opioids are a significant public health concern, accounting for 2.88 million visits to emergency departments in the U.S. in 2016 and 2017, other drugs are also abused on a regular basis, including cocaine, amphetamines, and benzodiazepines.
In 1986, President Reagan directed federal agencies to achieve a drug-free work environment. Many private employers also employ drug testing to ensure their workplaces are safe. Approximately 20 million people are screened each year in the U.S. in workplace drug testing programs, said Amitava Dasgupta, PhD, professor of pathology and laboratory medicine at the University of Kansas Medical Center in Kansas City.
Dasgupta will discuss ways that people try to beat drug tests and strategies clinical laboratories can use to detect adulterated specimens during a roundtable session “How People Try to Beat Drug Testing and Defend Positive Results” at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo on July 24-28 in Chicago.
About 2% of people undergoing drug testing attempt to “beat” the tests, Dasgupta said. Some people try to beat drug tests by ingesting detoxifying agents designed to flush out drugs and metabolites. Others add adulterants to their urine, such as common household chemicals –laundry bleach, table salt, toilet bowl cleaner, and vinegar. While these types of adulterants are fairly easy to identify, there are chemicals that can be purchased online that are more difficult to identify in urine. In addition, some individuals purchase synthetic urine online in an attempt to beat drug tests in settings where collection of a urine specimen is not supervised.
When attempts to beat drug tests fail and a test comes back positive, individuals sometimes blame the positive result on other issues, such as eating food with poppyseeds, inhaling second-hand marijuana smoke, or taking CBD products for pain.
Dasgupta will also discuss ways to debunk common defenses of positive drug tests. “This is a very important topic because we want to have a drug-free workplace, and lab medicine professionals who are involved in the field of toxicology testing play a big role in helping ensure a safe workplace,” he said. “It’s important to know ways in which people can try to beat drug tests so you know what to look out for.”
Among the topics that will be covered during this session:
“There are 14,000 sites on the internet that tell you how to beat a drug test, Dasgupta noted. “My goal is to make sure that toxicologists know how people try to beat tests so they can be prepared in advance.”
In 1986, President Reagan directed federal agencies to achieve a drug-free work environment. Many private employers also employ drug testing to ensure their workplaces are safe. Approximately 20 million people are screened each year in the U.S. in workplace drug testing programs, said Amitava Dasgupta, PhD, professor of pathology and laboratory medicine at the University of Kansas Medical Center in Kansas City.
Dasgupta will discuss ways that people try to beat drug tests and strategies clinical laboratories can use to detect adulterated specimens during a roundtable session “How People Try to Beat Drug Testing and Defend Positive Results” at the 2022 AACC Annual Scientific Meeting and Clinical Lab Expo on July 24-28 in Chicago.
About 2% of people undergoing drug testing attempt to “beat” the tests, Dasgupta said. Some people try to beat drug tests by ingesting detoxifying agents designed to flush out drugs and metabolites. Others add adulterants to their urine, such as common household chemicals –laundry bleach, table salt, toilet bowl cleaner, and vinegar. While these types of adulterants are fairly easy to identify, there are chemicals that can be purchased online that are more difficult to identify in urine. In addition, some individuals purchase synthetic urine online in an attempt to beat drug tests in settings where collection of a urine specimen is not supervised.
When attempts to beat drug tests fail and a test comes back positive, individuals sometimes blame the positive result on other issues, such as eating food with poppyseeds, inhaling second-hand marijuana smoke, or taking CBD products for pain.
Dasgupta will also discuss ways to debunk common defenses of positive drug tests. “This is a very important topic because we want to have a drug-free workplace, and lab medicine professionals who are involved in the field of toxicology testing play a big role in helping ensure a safe workplace,” he said. “It’s important to know ways in which people can try to beat drug tests so you know what to look out for.”
Among the topics that will be covered during this session:
- What are common household chemicals that are often used to adulterate urine?
- What are commercially available products used to beat drug tests and how can you recognize when they are being used?
- How can you differentiate natural urine from synthetic urine?
- Protocols for detecting specific adulterants.
- What are common defenses for a positive drug test and how they can be debunked?
“There are 14,000 sites on the internet that tell you how to beat a drug test, Dasgupta noted. “My goal is to make sure that toxicologists know how people try to beat tests so they can be prepared in advance.”
Latest AACC 2022 News
- AACC 2022 Review: International Meetings Rebound After Suffering Long COVID Hiatus
- Faster Method Diagnoses Pediatric Urinary Tract Infections
- Tianlong Showcases Integrated PCR Lab Solutions at AACC 2022
- Cellavision Introduces New Workflow Solution for Low-Volume Hematology Labs at AACC 2022
- Advanced Instruments Introduces New Automated Osmometer at AACC 2022
- Innovative Smartphone and AI-Based Tests Featured at AACC 2022
- New Tests Presented at AACC 2022 to Solve Challenges in Children's Healthcare
- 10-Minute Sepsis Risk Stratification Test Introduced at AACC 2022
- New System Combining DNA/RNA Extraction and Smart PCR Setup Launched at AACC 2022
- Novel Small Volume Blood Collection Device Launched at AACC 2022
- AACC Disruptive Technology Award Finalists Tackle Cancer, Women's Health, and STDs
- Meridian Demonstrates State-of-the-Art Urea Breath Test System at AACC 2022
- Nikon Instruments Displays Latest Clinical Pathology Products at AACC 2022
- Seegene Showcases Latest Molecular Testing Solutions at AACC 2022
- Werfen Introduces New Acute Care Diagnostic Products for CVOR at AACC 2022
- PerkinElmer Demonstrates Vanadis NIPT Screening Platform Featuring Groundbreaking cfDNA Technology
Channels
Clinical Chemistry
view channel
Study Supports Review of Long-Term Blood-Monitoring Guidelines for Clozapine
Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia for which clozapine remains the only antipsychotic specifically approved by the U.S. Food and Drug Administration (FDA).... Read more
Plasma Assay Measures Six Amyloid Beta Peptides for Alzheimer’s Treatment Research
Alzheimer’s disease research and related neurological studies often require tools that can characterize brain amyloid pathology and amyloid beta biology. Blood-based biomarker assays may help researchers... Read more
Blood Biomarker Model May Help Estimate Five- and 10-Year Cognitive Impairment Risk
Estimating future cognitive impairment risk remains challenging in cognitively healthy adults, particularly when biomarker findings are reduced to simple positive or negative results. Because mild cognitive... Read moreMolecular Diagnostics
view channel
Genetic Test Improves Risk Prediction for Open-Angle Glaucoma
Glaucoma damages the optic nerve and is the leading cause of irreversible blindness worldwide. Because the disease often causes no early symptoms, about half of affected individuals remain undiagnosed... Read more
Protein-Based Classifier Shows Promise for Predicting Melanoma Treatment Outcomes
Immune checkpoint inhibitors have improved melanoma treatment and extended survival over the past 15 years. However, many patients do not respond, and reliable biomarkers for predicting treatment response... Read moreHematology
view channel
Werfen Gains FDA Clearance for ROTEM sigma Cartridge Use in Trauma
Traumatic injuries account for approximately 10% of deaths worldwide, with uncontrolled bleeding remaining a leading cause of potentially preventable trauma-related death. Trauma-induced coagulopathy further... Read more
Serial Blood Samples Reveal Leukemia’s Evolution Decades Before Diagnosis
Acute myeloid leukemia (AML) is an aggressive blood cancer affecting approximately 2,700 people in the U.K. annually, with only about one in six patients surviving five years after diagnosis.... Read moreImmunology
view channel
Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice
Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more
Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis
Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more
Antibody Testing Informs Melioidosis Diagnosis and Surveillance in Emerging Regions
Melioidosis is a serious and sometimes fatal infection caused by the soil- and water-dwelling bacterium Burkholderia pseudomallei. People and animals can contract the disease through exposure to contaminated... Read moreMicrobiology
view channel
WHO Survey Reveals Gaps in Antimicrobial Resistance Testing and Response
Antimicrobial resistance (AMR) remains a major challenge for health systems, limiting effective treatment options for drug-resistant infections. These infections caused more than 1 million deaths and contributed... Read more
Direct-From-Specimen Pneumonia Test Detects Pathogens and Resistance in Hours
Pneumonia is a leading cause of sepsis and is associated with high mortality. Conventional culture-based pathogen identification and antimicrobial susceptibility testing can take two to four days, delaying... Read morePathology
view channel
AI Prostate Cancer Test Added to NCCN Guidelines for Post-Surgery Recurrence
Following radical prostatectomy, an estimated 20% to 40% of prostate cancer patients develop biochemical recurrence, marked by rising prostate-specific antigen levels that may indicate cancer recurrence.... Read more
New Training Approach Helps AI Distinguish Neighboring Cells in Tissue
Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more
Review Highlights Progress and Validation Needs for AI in Digital Pathology
Pathology remains the gold standard for disease diagnosis, but clinical laboratories face growing demands for faster, more reproducible diagnostic and prognostic workflows. Digital pathology based on whole-slide... Read moreTechnology
view channel
New qPCR Master Mixes Offer Broad Compatibility for Routine Research
Quantitative PCR (qPCR) workflows require consistent reagent performance across instruments and assay formats. Laboratories must also manage costs without changing established protocols.... Read more
Multi-Agent AI Framework Supports Laboratory Quality and Workflow Monitoring
Clinical laboratories analyze blood, urine, tissue, and other bodily fluids to support disease diagnosis and treatment. Rising test volumes, workforce shortages, and increasingly complex diagnostics are... Read moreIndustry
view channel
Labcorp Partners With Grupo Fleury to Expand Clinical Trial Operations in Brazil
Multinational clinical trials require laboratory partners that combine global expertise with local operational capabilities. Brazil is an important clinical research destination, supported by its diverse... Read more








